Vitamin C, Glutathione, Or Lipoic Acid Did Not Decrease Brain Or Kidney Mercury In Rats Exposed To Mercury Vapor

References

• Godfrey M, Campbell N. Confirmation of mercury retention and toxicity using 2,3 dimercapto-1-propane sulphonic acid sodium salt (DMPS). J Adv Med 1994; 7: 19–30
   Google Scholar
• Chapman DW, Shaffer CF. Mercurial diuretics: a comparison of acute cardiac toxicity in animals and the effect of ascorbic acid on detoxification in their intravenous administration. Arch Int Med 1947; 79: 49–56
   Google Scholar
• Petrunkin VE. Synthesis and properties of dimercapto derivatives of alkylsulfonic acids. I: synthesis of sodium 2,3-dimercaptopropylsulfonate (unithiol) and sodium 2-mercaptoethylsulfonate. Ukr Khim Zh 1956; 22: 603–607
   Google Scholar
• Klimova KK. Pharmacology of a new unithiol antidote. Farmakol Toksikol (Moscow) 1956; 21: 53–59
   Google Scholar
• Aposhian HV. DMSA and DMPS: water-soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol 1983; 23: 193–215
   PubMed Web of Science ®Google Scholar
• Aposhian HV, Maiorino RM, Rivera M, Bruce DC, Dart RC, Hurlbut KM, Levine DJ, Zheng W, Fernando Q, Carter D, Aposhian MM. Human studies with the chelating agents DMPS and DMSA. Clin Toxicol 1992; 30: 505–528
   Web of Science ®Google Scholar
• Aposhian HV, Bruce DC, Alter W, Dart RC, Hurlbut KM, Aposhian MM. Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score. FASEB J 1992; 6: 2472–2476
   PubMed Web of Science ®Google Scholar
• Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 1995; 97: 23–28
   PubMed Web of Science ®Google Scholar
• Gonzalez-Ramirez D, Zuniga-Charles M, Narro-Juarez A, Molina-Recio Y, Hurlbut KM, Dart RC, Aposhian HV. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther 1998; 287: 8–12
   PubMed Web of Science ®Google Scholar
• Aaseth J, Jacobsen D, Andersen O, Wickstrom E. Treatment of mercury and lead poisoning with dimercaptosuccinic acid and sodium dimercaptopropane-sulfonate: a review. Analyst 1995; 120: 23–28
   Web of Science ®Google Scholar
• Campbell JR, Clarkson TW, Omar MD. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning. JAMA 1986; 256: 3127–3130
   PubMed Web of Science ®Google Scholar
• de la Torre A, Belles M, Llobet JM, Mayayo E, Domingo JL. Comparison of the effectiveness of 2,3-dimercaptopropanol (BAL) and meso-2,3-dimercaptosuccinic acid (DMSA) as protective agents mercuric chloride-induced nephrotoxicity in rats. Biol Trace Element Res 1998; 63: 1–10
   PubMed Web of Science ®Google Scholar
• Schiele R, Schaller KH, Weltle D. Mobilization of mercury reserves in the organism by means of DMPS (dimaval). Occup Med Soc Med Prev Med 1989; 24: 249–251
   Google Scholar
• Buchet JP, Lauwerys RR. Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors. Toxicology 1989; 54: 323–333
   PubMed Web of Science ®Google Scholar
• Sallsten G, Barregard L, Schutz A. Clearance half life of mercury in urine after the cessation of long term occupational exposure: influence of a chelating agent (DMPS) on excretion of mercury in urine. Occup Environ Med 1994; 51: 337–342
   PubMed Web of Science ®Google Scholar
• Graziano JH. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1986; 1: 155–162
   PubMedGoogle Scholar
• Ding GS, Liang YY. Antidotal effects of dimercaptosuccinic acid. J Appl Toxicol 1991; 11: 7–14
   PubMed Web of Science ®Google Scholar
• Aposhian HV, Aposhian MM. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Toxicol 1990; 30: 279–306
   PubMed Web of Science ®Google Scholar
• Forman J, Moline J, Cernichiari E, Sayegh S, Torres JC, Landrigan MM, Hudson J, Adel HN, Landrigan PJ. A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA). Environ Health Persp 2000; 108: 575–577
   PubMed Web of Science ®Google Scholar
• Agoca MM, Etzel RA, Parrish RG, Paschal DC, Campagna PR, Cohen DS, Kilbourne EM, Hesse JL. Mercury exposure from interior latex paint. N Engl J Med 1990; 323: 1096–1101
   PubMed Web of Science ®Google Scholar
• Roels HA, Boeckx M, Ceulemans E, Lauwerys RR. Urinary excretion of mercury after occupational exposure to mercury vapor and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Br J Ind Med 1991; 48: 247–253
   PubMedGoogle Scholar
• Toxicological Effects of Methylmercury. National Academy Press, Washington, DC 2000
   Google Scholar
• Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci 1997; 34: 369–440
   PubMed Web of Science ®Google Scholar
• Environmental Health Criteria for Inorganic Mercury. World Health Organization, Geneva 1991; 118
   Google Scholar
• Lorscheider FL, Vimy MJ, Summers AO. Mercury exposure from ‘silver’ tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J 1995; 9: 504–508
   PubMed Web of Science ®Google Scholar
• Bluhm RE, Bobbitt RG, Welch LW, Wood AJ, Bonfiglio JF, Sarzen C, Heath AJ, Branch RA. Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part I: history, neuropsychological findings and chelator effects. Hum Exp Toxicol 1992; 11: 201–210
   PubMed Web of Science ®Google Scholar
• Lund ME, Banner W, Clarkson TW, Berlin M. Treatment of acute methylmercury ingestion by hemodialysis with N-acetylcysteine (mucomyst) infusion and 2,3-dimercaptopropane sulfonate. Clin Toxicol 1984; 22: 31–49
   Web of Science ®Google Scholar
• Ayre SG, Skaletski B, Mosnaim AD. Blood-brain passage of azzidotymidine in rats: effect of insulin. Res Commun Chem Path Pharmacol 1989; 39: 129–134
   Google Scholar
• Dirks MJ, Davis DR, Cheraskin E, Jackson JA. Mercury excretion and intravenous ascorbic acid. Arch Environ Health 1994; 49: 49–52
   PubMed Web of Science ®Google Scholar
• Leong CCW, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. NeuroReport 2000; 12: 733–737
   Web of Science ®Google Scholar
• , Autism Research Institute, San Diego, California. Mercury Detoxification Consensus Group Position Paper May 2001.
   Google Scholar
• Bustamante J, Lodge JK, Marocci L, Tritschler HJ. Alpha-DHLP in liver metabolism and disease. Free Rad Biol Med 1998; 24: 1023–1039
   PubMed Web of Science ®Google Scholar
• Johnson FC. Antioxidant vitamins. CRC Crit Rev Food Sci Nutr 1979; 11: 217–309
   PubMedGoogle Scholar
• Jungas T, Motta I, Duffieux F, Fanen P, Stoven V, Ojcius DM. Glutathione levels and BAX activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator. J Biol Chem 2002; 277: 27912–27918
   PubMed Web of Science ®Google Scholar
• Wilson CWM. The role of ascorbic acid in allergic reactions. Proc Nutr Soc 1976; 35: 121A
   PubMed Web of Science ®Google Scholar
• Zorn NE, Smith JT. A relationship between vitamin B12, folate, ascorbate, and mercury uptake and methylation. Life Sci 1990; 47: 167–173
   PubMed Web of Science ®Google Scholar
• Walsh CT, Distefano MD, Moore M, Shewchuk LM, Verdine GL. Molecular basis of bacterial resistance to organomercurial and inorganic mercuric salts. FASEB J 1988; 2: 124–130
   PubMed Web of Science ®Google Scholar